Abstract

Arsenic exposure has been associated with decreased club cell secretory protein (CC16) levels in adults. Further, both arsenic exposure and decreased levels of CC16 in childhood have been associated with decreased adult lung function. Our objective was to determine if urinary CC16 levels in children are associated with arsenic concentrations in environmental media collected from their homes. Yard soil, house dust, and tap water were taken from 34 homes. Urine and toenail samples were collected from 68 children. All concentrations were natural log-transformed prior to data analysis. There were associations between urinary CC16 and arsenic concentration in soil (b = −0.43, p = 0.001, R2 = 0.08), water (b = −0.22, p = 0.07, R2 = 0.03), house dust (b = −0.37, p = 0.07, R2 = 0.04), and dust loading (b = −0.21, p = 0.04, R2 = 0.04). In multiple analyses, only the concentration of arsenic in soil was associated with urinary CC16 levels (b = −0.42, p = 0.02, R2 = 0.14 (full model)) after accounting for other factors. The association between urinary CC16 and soil arsenic may suggest that localized arsenic exposure in the lungs could damage the airway epithelium and predispose children for diminished lung function. Future work to assess this possible mechanism should examine potential associations between airborne arsenic exposures, CC16 levels, lung function, and other possible confounders in children in arsenic-impacted communities.

Highlights

  • In the United States (US) and Canada, chronic obstructive pulmonary disease (COPD) is the second leading cause of disability-adjusted life years, while asthma is the 22nd leading cause [1]

  • We found that CC16 levels were more likely to be associated with external environmental measurements of arsenic, than urinary arsenic levels

  • In this exploratory study we determined that lower levels of CC16 in children’s urine may be associated with exposure to arsenic via multiple routes

Read more

Summary

Introduction

In the United States (US) and Canada, chronic obstructive pulmonary disease (COPD) is the second leading cause of disability-adjusted life years, while asthma is the 22nd leading cause [1]. Public Health 2016, 13, 521; doi:10.3390/ijerph13050521 www.mdpi.com/journal/ijerph

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call